Clinical Trial Update: BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy [Phase 2]

View source ↗

Summary

Phase 2 trial update for Nivolumab plus Gemcitabine and Cisplatin in muscle invasive bladder cancer undergoing cystectomy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• nivolumab (nivolumab)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Muscle Invasive Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-12-16